Codrituzumab
Primary Extra-cranial Solid Tumor
Memorial Sloan Kettering Cancer CenterPhase 1
—
Rating in progress
Codrituzumab in Primary Extra-cranial Solid Tumor is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.
Methodology v0.2 · Active